Codexis, Inc.
NASDAQ:CDXS
Overview | Financials
Company Name | Codexis, Inc. |
Symbol | CDXS |
Currency | USD |
Price | 4.97 |
Market Cap | 404,447,666 |
Dividend Yield | 0% |
52-week-range | 2.53 - 6.08 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Stephen George Dilly MBBS, Ph.D. |
Website | https://www.codexis.com |
An error occurred while fetching data.
About Codexis, Inc.
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protein engineering services. In
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD